Monterey, CA : April 2-7
Educational Grantee Partners:
13th Annual Conference & Exhibits
April 2 - 7, 2023
MSACL's mission is to support the community in overcoming the challenges of implementing high value tests in the clinical lab.
MSACL is focused on providing a forum of interaction for participants in all stages of the development, advancement and use of analytical tools, including data analytics, in the clinic to improve patient care. Although the group primarily focuses on mass spectrometry, presentations and discussion on other platforms are welcome.
The Monterey Conference Center (MCC) is flanked by two hotels, the Marriott, and the Portola. Each has meeting space and their own restaurant. Local sourcing is a priority. Portola also has a brewpub (Peter B’s).
We will be using the Monterey Conference Center’s Serra Ballroom as the MSACL Exhibit Hall (19,150 square feet). There will be space for at least 40 booths interspersed with up to 176 posters.
We typically have 800-900 attendees in a NORMAL year. This is 2nd post-pandemic event. We had 466 attendees for MSACL 2022. We are expecting about 520-600 for MSACL 2023 based on the increasing numbers seen at other similar conferences such as ASMS and AACC.
MSACL invests heavily in education via the MSACL Educational Grants, which support conference attendance:
In the past we have had specific tracks for each -omic topic area. For 2023, we are planning to focus on plenary sessions with panel discussions that bring the community together, in addition to parallel sessions on focused topics.
A list of the topics being solicited for the current conference is below.
Abstract Submission Categories for MSACL 2023
The target audience for this program includes pathologists, clinical laboratory directors and scientists, mass spectrometry and automated sample processing providers as well as laboratory diagnostic providers. This program will be beneficial to healthcare administrators, laboratory quality control and standards scientists, as well as those responsible for implementation of clinical analyses for emergency response due to terrorism or accident.
With the advancement of technologies for clinical analysis, there exists a gap between those who understand the technology and those who do not. Without continual education, this gap will grow and these advancements are unlikely to be effectively incorporated into the clinical analysis workflow, resulting in lost opportunities to improve patient outcomes and reduce healthcare costs.
MSACL provides an environment through which participants will be able to identify opportunities to develop the capacity to provide higher quality results, more rapidly and for lower overall cost, for patients within the healthcare system.